P/E ratio for OraSure Technologies (OSUR)
P/E ratio as of September 2023 (TTM): 9.84
According to OraSure Technologies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 9.84483. At the end of 2021 the company had a P/E ratio of -27.2.
P/E ratio history for OraSure Technologies from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | -27.2 | -38.46% |
| 2020 | -44.1 | -248.37% |
| 2019 | 29.7 | -13.43% |
| 2018 | 34.4 | -3.46% |
| 2017 | 35.6 | 41.85% |
| 2016 | 25.1 | -44.68% |
| 2015 | 45.4 | -135.78% |
| 2014 | -127 | 303.02% |
| 2013 | -31.5 | 27.03% |
| 2012 | -24.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 17.9 | 81.55% | 🇺🇸 USA |
 Cooper Companies COO | 57.8 | 487.29% | 🇺🇸 USA |
 Trinity Biotech
TRIB | -0.7882 | -108.01% | 🇮🇪 Ireland |
 QuidelOrtho QDEL | 104 | 959.08% | 🇺🇸 USA |
 Chembio Diagnostics CEMI | -0.3792 | -103.85% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -23.5 | -338.93% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.